Clinical Trials Browser

Phase 2 × icotinib × Head & Neck × Clear all

NCT02328261 2014-12-31

A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma